Search

Your search keyword '"Luong, Amber U."' showing total 277 results
Start Over Author "Luong, Amber U."
277 results on '"Luong, Amber U."'

11. The Joint Task Force on Practice Parameters GRADE guidelines for the medical management of chronic rhinosinusitis with nasal polyposis

Author

Rank, Matthew A., Chu, Derek K., Bognanni, Antonio, Oykhman, Paul, Bernstein, Jonathan A., Ellis, Anne K., Golden, David B.K., Greenhawt, Matthew, Horner, Caroline C., Ledford, Dennis K., Lieberman, Jay, Luong, Amber U., Orlandi, Richard R., Samant, Shefali A., Shaker, Marcus S., Soler, Zachary M., Stevens, Whitney W., Stukus, David R., Wang, Julie, and Peters, Anju T.

Published
2023
Full Text
View/download PDF

15. Topical corticosteroids for chronic rhinosinusitis with nasal polyposis: GRADE systematic review and network meta-analysis

Author

Bognanni, Antonio, Chu, Derek K., Rank, Matthew A., Bernstein, Jonathan, Ellis, Anne K., Golden, David, Greenhawt, Matthew, Hagan, John B., Horner, Caroline C., Ledford, Dennis K., Lieberman, Jay, Luong, Amber U., Marks, Lisa A., Orlandi, Richard R., Samant, Shefali A., Shaker, Marcus, Soler, Zachary M., Stevens, Whitney W., Stukus, David R., Wang, Julie, and Peters, Anju T.

Published
2022
Full Text
View/download PDF

17. Current Review of Comorbidities in Chronic Rhinosinusitis.

Author

Choi, Alexander, Xu, Shuhui, Luong, Amber U., and Wise, Sarah K.

Abstract

Purpose of Review: Chronic rhinosinusitis (CRS) is a heterogenous disease with a significant impact on patient quality of life and a substantial economic burden. CRS is associated with several systemic inflammatory conditions. We provide an updated review of CRS comorbidities as a springboard for future comorbidity mapping and potential therapeutics. Recent Findings: The link between environmental allergies and CRS is most evident for central compartment atopic disease (CCAD) and allergic fungal rhinosinusitis (AFRS) subtypes but remains inconclusive for CRS overall. The association between asthma and CRS, reinforced by the unified airway theory, is evidenced by their response to similar biologic therapies. Another lower respiratory tract disease, COPD, has up to a 50% co-occurrence with CRS and warrants careful screening and treatment. Eosinophilic esophagitis and CRS share eosinophilic inflammation in different sites, meriting further research. Obesity not only presents physiological challenges but also correlates with a more severe subset of CRS. Diabetes mellitus is associated with CRSwNP, possibly secondary to therapeutics with steroids. Autoimmunity may contribute to nasal polyp formation through cytokines such as B-cell activating factor (BAFF), offering potential for future therapeutics. Summary: This review illustrates the need to employ a macroscopic approach in clinical decision making and treatment of CRS. Comorbidities may contribute to an overall proinflammatory state, magnify severity of symptoms, be a source of treatment resistance, and even an opportunity for future therapeutics. [ABSTRACT FROM AUTHOR]

Published
2025
Full Text
View/download PDF

20. International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis

Author

Wise, Sarah K, Lin, Sandra Y, Toskala, Elina, Orlandi, Richard R, Akdis, Cezmi A, Alt, Jeremiah A, Azar, Antoine, Baroody, Fuad M, Bachert, Claus, Canonica, G Walter, Chacko, Thomas, Cingi, Cemal, Ciprandi, Giorgio, Corey, Jacquelynne, Cox, Linda S, Creticos, Peter Socrates, Custovic, Adnan, Damask, Cecelia, DeConde, Adam, DelGaudio, John M, Ebert, Charles S, Eloy, Jean Anderson, Flanagan, Carrie E, Fokkens, Wytske J, Franzese, Christine, Gosepath, Jan, Halderman, Ashleigh, Hamilton, Robert G, Hoffman, Hans Jürgen, Hohlfeld, Jens M, Houser, Steven M, Hwang, Peter H, Incorvaia, Cristoforo, Jarvis, Deborah, Khalid, Ayesha N, Kilpeläinen, Maritta, Kingdom, Todd T, Krouse, Helene, Larenas-Linnemann, Desiree, Laury, Adrienne M, Lee, Stella E, Levy, Joshua M, Luong, Amber U, Marple, Bradley F, McCoul, Edward D, McMains, K Christopher, Melén, Erik, Mims, James W, Moscato, Gianna, Mullol, Joaquim, Nelson, Harold S, Patadia, Monica, Pawankar, Ruby, Pfaar, Oliver, Platt, Michael P, Reisacher, William, Rondón, Carmen, Rudmik, Luke, Ryan, Matthew, Sastre, Joaquin, Schlosser, Rodney J, Settipane, Russell A, Sharma, Hemant P, Sheikh, Aziz, Smith, Timothy L, Tantilipikorn, Pongsakorn, Tversky, Jody R, Veling, Maria C, Wang, De Yun, Westman, Marit, Wickman, Magnus, and Zacharek, Mark

Subjects
Allergic Rhinitis (Hay Fever), Adrenal Cortex Hormones, Allergens, Biological Products, Complementary Therapies, Cytokines, Diagnosis, Differential, Drug Therapy, Combination, Endoscopy, Environmental Exposure, Epidemiologic Methods, Histamine Antagonists, Humans, Immunoglobulin E, Microbiota, Nasal Decongestants, Occupational Diseases, Physical Examination, Probiotics, Quality of Life, Respiratory Mucosa, Rhinitis, Allergic, Risk Factors, Saline Solution, Skin Tests, Socioeconomic Factors, allergen extract, allergy, allergen immunotherapy, allergic rhinitis, antihistamine, asthma, atopic dermatitis, avoidance, biologic, cockroach, conjunctivitis, consensus, corticosteroid, cough, cromolyn, decongestant, eosinophilic esophagitis, environment, epicutaneous immunotherapy, epidemiology, evidence-based medicine, food allergy, genetics, house dust mite, IgE, immunoglobulin E, immunotherapy, inhalant allergy, leukotriene, microbiome, occupational rhinitis, omalizumab, pathophysiology, perennial, pet dander, pollen, probiotic, quality of life, rhinitis, rhinosinusitis, risk factor, saline, seasonal, sensitization, sinusitis, sleep, socioeconomic, specific IgE, subcutaneous immunotherapy, sublingual immunotherapy, systematic review, total IgE, transcutaneous immunotherapy, validated survey, Immunology
Abstract

BackgroundCritical examination of the quality and validity of available allergic rhinitis (AR) literature is necessary to improve understanding and to appropriately translate this knowledge to clinical care of the AR patient. To evaluate the existing AR literature, international multidisciplinary experts with an interest in AR have produced the International Consensus statement on Allergy and Rhinology: Allergic Rhinitis (ICAR:AR).MethodsUsing previously described methodology, specific topics were developed relating to AR. Each topic was assigned a literature review, evidence-based review (EBR), or evidence-based review with recommendations (EBRR) format as dictated by available evidence and purpose within the ICAR:AR document. Following iterative reviews of each topic, the ICAR:AR document was synthesized and reviewed by all authors for consensus.ResultsThe ICAR:AR document addresses over 100 individual topics related to AR, including diagnosis, pathophysiology, epidemiology, disease burden, risk factors for the development of AR, allergy testing modalities, treatment, and other conditions/comorbidities associated with AR.ConclusionThis critical review of the AR literature has identified several strengths; providers can be confident that treatment decisions are supported by rigorous studies. However, there are also substantial gaps in the AR literature. These knowledge gaps should be viewed as opportunities for improvement, as often the things that we teach and the medicine that we practice are not based on the best quality evidence. This document aims to highlight the strengths and weaknesses of the AR literature to identify areas for future AR research and improved understanding.

Published
2018

23. Evaluation and treatment of rhinosinusitis with primary antibody deficiency in children: Evidence‐based review with recommendations.

Author

Makary, Chadi A., Azar, Antoine, Gudis, David, Crawford, Anna, Hannikainen, Paavali, Kim, Jean, Joe, Stephanie, Kimple, Adam J., Lam, Kent, Lee, Jivianne T., Luong, Amber U., Marcus, Sonya, McArdle, Erica, Mullings, Warren, Peppers, Brian P., Lewandrowski, Callum, Lin, Sandra Y., Ramadan, Hassan H., Rose, Austin S., and Ryan, Lindsey

Published
2024
Full Text
View/download PDF

26. EUFOREA/EPOS2020 statement on the clinical considerations for CRSwNP care

Author

Hellings, Peter W., primary, Alobid, Isam, additional, Anselmo‐Lima, Wilma T., additional, Bernal‐Sprekelsen, Manuel, additional, Bjermer, Leif, additional, Caulley, Lisa, additional, Chaker, Adam, additional, Constantinidis, Jannis, additional, Conti, Diego M., additional, De Corso, Eugenio, additional, Desrosiers, Martin, additional, Diamant, Zuzana, additional, Gevaert, Philippe, additional, Han, Joseph K., additional, Heffler, Enrico, additional, Hopkins, Claire, additional, Landis, Basile N., additional, Lourenco, Olga, additional, Lund, Valerie, additional, Luong, Amber U., additional, Mullol, Joaquim, additional, Peters, Anju, additional, Philpott, Carl, additional, Reitsma, Sietze, additional, Ryan, Dermot, additional, Scadding, Glenis, additional, Senior, Brent, additional, Tomazic, Peter Valentin, additional, Toskala, Elina, additional, Van Zele, Thibaut, additional, Viskens, An‐Sofie, additional, Wagenmann, Martin, additional, and Fokkens, W. J., additional

Published
2023
Full Text
View/download PDF

30. Acoustic resonance therapy is safe and effective for the treatment of nasal congestion in rhinitis: A randomized sham‐controlled trial

Author

Luong, Amber U., primary, Yong, Michael, additional, Hwang, Peter H., additional, Lin, Bryant Y., additional, Gopi, Paramesh, additional, Mohan, Vivek, additional, Ma, Yifei, additional, Johnson, Jacob, additional, Yen, David M., additional, DeMera, Richard S., additional, and Bleier, Benjamin S., additional

Published
2023
Full Text
View/download PDF

31. International consensus statement on allergy and rhinology: Sinonasal tumors

Author

Kuan, Edward C., primary, Wang, Eric W., additional, Adappa, Nithin D., additional, Beswick, Daniel M., additional, London, Nyall R., additional, Su, Shirley Y., additional, Wang, Marilene B., additional, Abuzeid, Waleed M., additional, Alexiev, Borislav, additional, Alt, Jeremiah A., additional, Antognoni, Paolo, additional, Alonso‐Basanta, Michelle, additional, Batra, Pete S., additional, Bhayani, Mihir, additional, Bell, Diana, additional, Bernal‐Sprekelsen, Manuel, additional, Betz, Christian S., additional, Blay, Jean‐Yves, additional, Bleier, Benjamin S., additional, Bonilla‐Velez, Juliana, additional, Callejas, Claudio, additional, Carrau, Ricardo L., additional, Casiano, Roy R., additional, Castelnuovo, Paolo, additional, Chandra, Rakesh K., additional, Chatzinakis, Vasileios, additional, Chen, Simon B., additional, Chiu, Alexander G., additional, Choby, Garret, additional, Chowdhury, Naweed I., additional, Citardi, Martin J., additional, Cohen, Marc A., additional, Dagan, Roi, additional, Dalfino, Gianluca, additional, Dallan, Iacopo, additional, Dassi, Camila Soares, additional, de Almeida, John, additional, Tos, Angelo P. Dei, additional, DelGaudio, John M., additional, Ebert, Charles S., additional, El‐Sayed, Ivan H., additional, Eloy, Jean Anderson, additional, Evans, James J., additional, Fang, Christina H., additional, Farrell, Nyssa F., additional, Ferrari, Marco, additional, Fischbein, Nancy, additional, Folbe, Adam, additional, Fokkens, Wytske J., additional, Fox, Meha G., additional, Lund, Valerie J., additional, Gallia, Gary L., additional, Gardner, Paul A., additional, Geltzeiler, Mathew, additional, Georgalas, Christos, additional, Getz, Anne E., additional, Govindaraj, Satish, additional, Gray, Stacey T., additional, Grayson, Jessica W., additional, Gross, Bradley A., additional, Grube, Jordon G., additional, Guo, Ruifeng, additional, Ha, Patrick K., additional, Halderman, Ashleigh A., additional, Hanna, Ehab Y., additional, Harvey, Richard J., additional, Hernandez, Stephen C., additional, Holtzman, Adam L., additional, Hopkins, Claire, additional, Huang, Zhigang, additional, Huang, Zhenxiao, additional, Humphreys, Ian M., additional, Hwang, Peter H., additional, Iloreta, Alfred M., additional, Ishii, Masaru, additional, Ivan, Michael E., additional, Jafari, Aria, additional, Kennedy, David W., additional, Khan, Mohemmed, additional, Kimple, Adam J., additional, Kingdom, Todd T., additional, Knisely, Anna, additional, Kuo, Ying‐Ju, additional, Lal, Devyani, additional, Lamarre, Eric D., additional, Lan, Ming‐Ying, additional, Le, Hien, additional, Lechner, Matt, additional, Lee, Nancy Y., additional, Lee, Jivianne K., additional, Lee, Victor H., additional, Levine, Corinna G., additional, Lin, Jin‐Ching, additional, Lin, Derrick T., additional, Lobo, Brian C., additional, Locke, Tran, additional, Luong, Amber U., additional, Magliocca, Kelly R., additional, Markovic, Svetomir N., additional, Matnjani, Gesa, additional, McKean, Erin L., additional, Meço, Cem, additional, Mendenhall, William M., additional, Michel, Loren, additional, Na'ara, Shorook, additional, Nicolai, Piero, additional, Nuss, Daniel W., additional, Nyquist, Gurston G., additional, Oakley, Gretchen M., additional, Omura, Kazuhiro, additional, Orlandi, Richard R., additional, Otori, Nobuyoshi, additional, Papagiannopoulos, Peter, additional, Patel, Zara M., additional, Pfister, David G., additional, Phan, Jack, additional, Psaltis, Alkis J., additional, Rabinowitz, Mindy R., additional, Ramanathan, Murugappan, additional, Rimmer, Ryan, additional, Rosen, Marc R., additional, Sanusi, Olabisi, additional, Sargi, Zoukaa B., additional, Schafhausen, Philippe, additional, Schlosser, Rodney J., additional, Sedaghat, Ahmad R., additional, Senior, Brent A., additional, Shrivastava, Raj, additional, Sindwani, Raj, additional, Smith, Timothy L., additional, Smith, Kristine A., additional, Snyderman, Carl H., additional, Solares, C. Arturo, additional, Sreenath, Satyan B., additional, Stamm, Aldo, additional, Stölzel, Katharina, additional, Sumer, Baran, additional, Surda, Pavol, additional, Tajudeen, Bobby A., additional, Thompson, Lester D. R., additional, Thorp, Brian D., additional, Tong, Charles C. L., additional, Tsang, Raymond K., additional, Turner, Justin H., additional, Turri‐Zanoni, Mario, additional, Udager, Aaron M., additional, van Zele, Thibaut, additional, VanKoevering, Kyle, additional, Welch, Kevin C., additional, Wise, Sarah K., additional, Witterick, Ian J., additional, Won, Tae‐Bin, additional, Wong, Stephanie N., additional, Woodworth, Bradford A., additional, Wormald, Peter‐John, additional, Yao, William C., additional, Yeh, Chien‐Fu, additional, Zhou, Bing, additional, Palmer, James N., additional, Abiri, Arash, additional, Adams, Carrie D., additional, Ayoub, Noel F., additional, Bitner, Benjamin F., additional, Boyd, Jacob T., additional, Chang, Michael T., additional, Chapurin, Nikita, additional, Chaskes, Mark B., additional, Chua, Andy, additional, Chung, Sei Y., additional, Contrera, Kevin J., additional, Dilley, Katelyn K., additional, Dutra, André Zanette, additional, Eide, Jacob G., additional, Fenberg, Rachel, additional, Godse, Neal R., additional, Jawad, Basit, additional, Johnson, Jared, additional, Johnson, B. Jake, additional, Judd, Ryan, additional, Khalife, Sarah, additional, Khosravi, Pooya, additional, Kolarski, Mirko Manojlovic, additional, Kong, Keonho A., additional, Kshirsagar, Rijul S., additional, Lee, Joseph S., additional, Lin, Tian‐Yun, additional, McCormick, Justin P., additional, Melder, Katie, additional, Morse, Elliot, additional, Nguyen, Theodore V., additional, Norwood, Timothy G., additional, Pang, Jonathan C., additional, Parsel, Sean M., additional, Patel, Prayag S., additional, Ringel, Barak, additional, Schneider, Alexander L., additional, Spielman, Daniel B., additional, Spock, Todd, additional, and Vasudev, Milind, additional

Published
2023
Full Text
View/download PDF

33. Acoustic resonance therapy is safe and effective for the treatment of nasal congestion in rhinitis: A randomized sham-controlled trial.

Author

Luong, Amber U., Yong, Michael, Hwang, Peter H., Lin, Bryant Y., Gopi, Paramesh, Mohan, Vivek, Yifei Ma, Johnson, Jacob, Yen, David M., DeMera, Richard S., and Bleier, Benjamin S.

Subjects
*ACOUSTIC resonance, *RHINITIS, *CLINICAL trials, *TRANSCRANIAL direct current stimulation, *CONFIDENCE intervals, *PARANASAL sinuses
Abstract

Background: Acoustic resonance therapy (ART) is a novel vibrational treatment that delivers patient-specific resonant frequency acoustic energy to the sinonasal cavities. In a pilot study, ART was effective for the acute treatment of nasal congestion. We conducted a sham-controlled randomized trial to validate the efficacy of ART when administered daily for 2 weeks. Methods: A total of 52 adult patients were enrolled in a multi-center, randomized, double-blinded, sham-controlled, interventional study evaluating ART administered by a vibrational headband. Patients received either active treatment or a non-therapeutic sham treatment twice daily over 2 weeks. Clinical endpoints were the average change in nasal congestion sub-score of the Total Nasal Symptom Score (TNSS) and the average change in composite TNSS. Results: ART resulted in a significantly greater mean change in the nasal congestion sub-score compared to sham (-0.87 [95% confidence interval [CI] -1.11, -0.62] vs. -0.44 [95% CI -0.64, -0.23], p = 0.008). ART also resulted in a significantly greater reduction in the composite TNSS versus sham, (-2.85 [95% CI -3.85,-1.85], vs.-1.32 [95% CI-2.27,-0.36], p=0.027). The response rate, determined by a nasal congestion sub-score minimal clinically important difference of 0.23, was 80.8% for ART and 46.2% for sham, with an adjusted risk ratio of 1.95 (95% CI 1.26, 3.02, p=0.003) in favor of ART. Safety endpoints showed no adverse events. Conclusion: ART is a safe and effective non-pharmacologic alternative for the treatment of nasal congestion. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

34. EUFOREA/EPOS2020 statement on the clinical considerations for chronic rhinosinusitis with nasal polyps care.

Author

Hellings, Peter W., Alobid, Isam, Anselmo‐Lima, Wilma T., Bernal‐Sprekelsen, Manuel, Bjermer, Leif, Caulley, Lisa, Chaker, Adam, Constantinidis, Jannis, Conti, Diego M., De Corso, Eugenio, Desrosiers, Martin, Diamant, Zuzana, Gevaert, Philippe, Han, Joseph K., Heffler, Enrico, Hopkins, Claire, Landis, Basile N., Lourenco, Olga, Lund, Valerie, and Luong, Amber U.

Subjects
NASAL polyps, ENDOSCOPIC surgery, SINUSITIS, REOPERATION, PHYSICIANS, ASPIRIN
Abstract

Following the European Forum for Research and Education in Allergy and Airway Diseases (EUFOREA) treatment algorithm for chronic rhinosinusitis (CRS) with nasal polyps (CRSwNP), patients suffering from severe uncontrolled CRSwNP are recommended to receive oral corticosteroids, (revision) sinus surgery, systemic biologicals and/or aspirin treatment after desensitization (ATAD). Given the major differences in indications, outcomes, practical considerations, risks and costs of these key pillars of treatment, there is a growing need to define criteria for each treatment option and list the clinically relevant and major considerations for them. This EUFOREA document therefore provides an expert panel overview of the expected outcomes, specific considerations and (contra)indications of the five major treatment arms of severe uncontrolled CRSwNP: oral corticosteroids, primary and revision sinus surgery, biological treatment and ATAD. This overview of treatment considerations is needed to allow physicians and patients to consider the different options in the context of providing optimal and personalized care for severe uncontrolled CRSwNP. In conclusion, the five major treatment options for severe uncontrolled CRSwNP have intrinsic advantages, specific indications and considerations that are of importance to the patient, the physician and the society. This EUFOREA statement supports the unmet need to define criteria for the indication of every treatment pillar of CRSwNP. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

35. Evaluation and treatment of rhinosinusitis with primary antibody deficiency in adults: Evidence‐based review with recommendations

Author

Makary, Chadi A., primary, Luong, Amber U., additional, Azar, Antoine, additional, Kim, Jean, additional, Ahmed, Omar G., additional, Chaaban, Mohamad, additional, Damask, Cecilia C., additional, Hannikainen, Paavali, additional, Joe, Stephanie, additional, Lam, Kent, additional, Peppers, Brian P., additional, Peters, Anju T., additional, Toskala, Elina, additional, and Lin, Sandra Y., additional

Published
2023
Full Text
View/download PDF

37. Contributors

Author

Adappa, Nithin D., primary, Adelson, Robert T., additional, Antunes, Marcelo, additional, Balsalobre, Leonardo, additional, Barham, Henry P., additional, Becker, Daniel G., additional, Becker, Samuel S., additional, Bleier, Benjamin S., additional, Chandra, Rakesh, additional, Chiu, Alexander G., additional, Choby, Garret, additional, Citardi, Martin J., additional, Cohen, Noam, additional, Conley, David B., additional, Fakhri, Samer, additional, Ference, Elisabeth H., additional, Govindaraj, Satish, additional, Grayson, Jessica, additional, Harsh, Griffith R., additional, Harvey, Richard J., additional, Hwang, Peter H., additional, Iloreta, Alfred Marc C., additional, Joe, Stephanie A., additional, Kingdom, Todd T., additional, Kuan, Edward C., additional, Lee, Jivianne T., additional, Lee, John M., additional, Leung, Randy, additional, Lobo, Brian C., additional, Luong, Amber U., additional, Lupa, Michael, additional, Man, Li-Xing, additional, Mantravadi, Avinash V., additional, Mattos, Jose, additional, Miyake, Marcel Menon, additional, Naidoo, Yuresh, additional, Nayak, Jayakar V., additional, O’Malley, Bert W., additional, Orlandi, Richard, additional, Palmer, James N., additional, Parasher, Arjun, additional, Pearlman, Aaron N., additional, Nagata Pignatari, Shirley Shizue, additional, Ramakrishnan, Vijay R., additional, Reed, Jeremy, additional, Sacks, Raymond, additional, Sansoni, E. Ritter, additional, Schlosser, Rodney, additional, Sindwani, Raj, additional, Sivasubramaniam, Rahuram, additional, Stamm, Aldo Cassol, additional, Suh, Jeffrey D., additional, Thamboo, Andrew, additional, Vaezeafshar, Reza, additional, Vandergrift, William A., additional, Wang, Eric W., additional, Wei, Calvin, additional, Welch, Kevin C., additional, Woodworth, Bradford A., additional, Wormald, P.J., additional, and Yip, Jonathan, additional

Published
2019
Full Text
View/download PDF

45. Indications for absorbable steroid‐eluting sinus implants: Viewpoint via the Delphi method

Author

Lee, Victoria S., primary, Patel, Prayag, additional, O'Brien, Daniel, additional, Scangas, George A., additional, Campbell, Raewyn G., additional, Chandra, Rakesh, additional, Davis, Greg E., additional, Han, Joseph K, additional, Le, Christopher H., additional, Lee, Jivianne, additional, Luong, Amber U., additional, Poetker, David M., additional, Ramadan, Hassan, additional, Setzen, Michael, additional, Smith, Kristine, additional, Wise, Sarah, additional, Villwock, Jennifer, additional, and Ference, Elisabeth, additional

Published
2022
Full Text
View/download PDF

46. STAT6 Blockade Abrogates Aspergillus-Induced Eosinophilic Chronic Rhinosinusitis and Asthma, A Model of Unified Airway Disease

Author

Sun, Hua, primary, Damania, Ashish, additional, Mair, Megan L., additional, Otukoya, Eniola, additional, Li, Yi-Dong, additional, Polsky, Katherine, additional, Zeng, Yuying, additional, Alt, Jeremiah A., additional, Citardi, Martin J., additional, Corry, David B., additional, Luong, Amber U., additional, and Knight, John Morgan, additional

Published
2022
Full Text
View/download PDF

49. What is allergic fungal sinusitis: A call to action

Author

Kim, Jean, primary, Makary, Chadi A., additional, Roland, Lauren T., additional, Kuruvilla, Merin, additional, Lam, Kent, additional, Smith, Kristine A., additional, Magliocca, Kelly R., additional, Wise, Sarah K., additional, Toskala, Elina, additional, Fermin, Janmaris Marin, additional, Pashley, Catherine H., additional, Levy, Joshua M., additional, and Luong, Amber U., additional

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results